Subcutaneous insulin is the treatment of choice for noncritically ill patients. However, the use of sliding-scale insulin alone for hospitalized patients with diabetes is not recommended [19,30]. For hospitalized patients with type 1 diabetes, the use of basal insulin plus short- or rapid-acting...